Meeting Banner
Abstract #0844

Early Serial Functional Diffusion Mapping in Patients with Newly Diagnosed Glioblastoma During Combined Chemoradiation and Anti-Angiogenic Treatment

Pavlina Polaskova1, Marco C. Pinho1, Kyrre E. Emblem1, Jayashree Kalpathy-Cramer1, Dominique Jennings1, Elizabeth Gerstner2, A. Gregory Sorensen3, Alexander S.R. Guimaraes1, Tracy T. Batchelor2

1A.A. Martinos Center for Biomedical Imaging / Massachusetts General Hospital, Charlestown, MA, United States; 2Massachusetts General Hospital Cancer Center / Harvard Medical School, Boston, MA; 3Radiology, Harvard Medical School

Serial graded functional diffusion maps (fDM) provide a new insight into a glioblastoma patients response to therapy. It is challenging to choose one early time-point that would accurately predict the response to therapy, because the timing of significant changes (anti-vascular effect vs anti-tumor effect) is strongly dependent on the type of therapy. By looking at multiple time-points, our longitudinal assessment allows us to show early trends rather than one-time imaging changes. We found that continuous relative decrease in ADC at early time-points as shown by longitudinal FDM is associated with shorter survival.

Abstract PDF

Keywords

accurately acknowledge addition aged amount anti assess assessed assessment automated biomedical blue brain cancer choose coded color confirmed daily dark decreased decreasing determining diagnosed diffusion directly early eighteen emblem enhancing example experienced extracting fact feature females find flair functional general graded gray green growth hospital included informed inhibitor insight instead intra light limitation limited linear long longitudinal looking males maps medical metric might mixed model months natl newly normalized oded onset onwards overall patient patients pixel population possibly post potentially previous previously prior promising quantifying radiology received reflect registering repetition response reveals robust school seem sensitive sensitively serial short shorter shrinkage significantly split stable status strongly substantial subtraction survival therapy timing treatment trends tumor valuation vascular visits visual volumetric week weeks wise